Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTY720 in de novo adult renal transplant recipients
NCT00239863Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2004
- Primary completion
- May 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of fingolimod in kidney transplant rejection, sponsored by Novartis. Started May 2004; status: completed.
02
Drugs
fingolimod
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00239863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239863.